<--- Back to Details
First PageDocument Content
Medical research / Health / Clinical research / Pharmaceutical industry / Agencies of the European Union / Drug discovery / Pharmaceuticals policy / European Medicines Agency / Heads of Medicines Agencies / Clinical trial / Good clinical practice / Clinical Trials Directive
Date: 2012-05-16 01:59:10
Medical research
Health
Clinical research
Pharmaceutical industry
Agencies of the European Union
Drug discovery
Pharmaceuticals policy
European Medicines Agency
Heads of Medicines Agencies
Clinical trial
Good clinical practice
Clinical Trials Directive

Reflection Paper on ethical and GCP aspects of clinical trials

Add to Reading List

Source URL: www.fercap-sidcer.org

Download Document from Source Website

File Size: 293,26 KB

Share Document on Facebook

Similar Documents

87th HMA meeting HUMAN STAKEHOLDERS MEETING Malta, 22 February 2017 STAKEHOLDERS INFORMATION Press release Heads of EU Medicines Agencies meet stakeholders to discuss availability and access of good quality

DocID: 1vcH5 - View Document

91st meeting of Heads of Medicines Agencies Highlights from Stakeholders meeting The Heads of EU Medicines Agencies met with stakeholders to discuss the ongoing Brexit process and its impact from a medicines regulatory p

DocID: 1uZ8t - View Document

Heads of Medicines Agencies Highlights of the 91st HMA meeting Introduction The 91st meeting of the Heads of Medicines Agencies (HMA) was held from the 27th February to 2nd March 2018 in Lisbon during the Bulgarian Presi

DocID: 1uQ9R - View Document

86th HMA meeting Bratislava, 28-30 November 2016 Information for Stakeholders Heads of Medicines Agencies: Highlights of the 86th meeting The 86th meeting of the Heads of Medicines Agencies was held fromNovember 2

DocID: 1uP7o - View Document

78th HMA Meeting Rome, 27-28 November 2014 STAKEHOLDERS INFORMATION HEADS OF MEDICINES AGENCIES – JOINT SESSION on 27 November 2014

DocID: 1tOG3 - View Document